GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Epi Biotech Co Ltd (XKRX:446440) » Definitions » ROA %

Epi Biotech Co (XKRX:446440) ROA % : 0.00% (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Epi Biotech Co ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Epi Biotech Co's annualized Net Income for the quarter that ended in . 20 was ₩ Mil. Epi Biotech Co's average Total Assets over the quarter that ended in . 20 was ₩ 0 Mil. Therefore, Epi Biotech Co's annualized ROA % for the quarter that ended in . 20 was Not Available.

The historical rank and industry rank for Epi Biotech Co's ROA % or its related term are showing as below:

XKRX:446440's ROA % is not ranked *
in the Biotechnology industry.
Industry Median: -34.29
* Ranked among companies with meaningful ROA % only.

Epi Biotech Co ROA % Historical Data

The historical data trend for Epi Biotech Co's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epi Biotech Co ROA % Chart

Epi Biotech Co Annual Data
Trend
ROA %

Epi Biotech Co Semi-Annual Data
ROA %

Competitive Comparison of Epi Biotech Co's ROA %

For the Biotechnology subindustry, Epi Biotech Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epi Biotech Co's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Epi Biotech Co's ROA % distribution charts can be found below:

* The bar in red indicates where Epi Biotech Co's ROA % falls into.


;
;

Epi Biotech Co ROA % Calculation

Epi Biotech Co's annualized ROA % for the fiscal year that ended in . 20 is calculated as:

ROA %=Net Income (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Epi Biotech Co's annualized ROA % for the quarter that ended in . 20 is calculated as:

ROA %=Net Income (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is one times the annual (. 20) net income data. ROA % is displayed in the 30-year financial page.


Epi Biotech Co  (XKRX:446440) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

Note: The Net Income data used here is one times the annual (. 20) net income data. The Revenue data used here is one times the annual (. 20) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Epi Biotech Co ROA % Related Terms

Thank you for viewing the detailed overview of Epi Biotech Co's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Epi Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
32, Songdogwahak-ro, Rooms 1903 and 1904, 15th floor, M-dong, Yeonsu-gu, Incheon, KOR, 21984
Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin regeneration treatments to create commercially viable consumer products. The company specializes in hair loss treatment in Korea.

Epi Biotech Co Headlines

No Headlines